Profession Notes

Tobacco Money Slated for Research The state of Michigan will award life science research grants from part of its 1998 tobacco settlement money anticipated to total more than $8.5 billion over 25 years. As one of 46 states awarded in the settlement (N.S. Halim, "Tobacco Settlement," The Scientist, 13[22]:1, Nov. 8, 1999), Michigan plans to apportion $50 million annually for 20 years to universities, research institutions, and companies for health and aging research, as well as economic developm

Written byKate Devine
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The state of Michigan will award life science research grants from part of its 1998 tobacco settlement money anticipated to total more than $8.5 billion over 25 years. As one of 46 states awarded in the settlement (N.S. Halim, "Tobacco Settlement," The Scientist, 13[22]:1, Nov. 8, 1999), Michigan plans to apportion $50 million annually for 20 years to universities, research institutions, and companies for health and aging research, as well as economic development. According to Lee Katterman, assistant to the vice president for research, University of Michigan, "Several University presidents approached Michigan Governor John Engler to urge him to devote a portion of the tobacco settlement money to life science research and development as both an appropriate use of the money to further public health and the state's economy. [T]his approach complemented the academic strengths of the state's major research universities and reflected our confidence in continued federal funding for ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies